UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

Annals of oncology, 2014-06, Vol.25 (6), p.1128-1136

2014

Link zum Volltext

Verfügbarkeit prüfen

PALB2, a major susceptibility gene for breast cancer

Gynécologie, obstétrique, fertilité & sénologie, 2018-11, Vol.46 (10-11), p.701-705

2018

Link zum Volltext

Verfügbarkeit prüfen

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Familial cancer, 2018, Vol.17 (1), p.5-14

2018

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer management: The change is now!

Gynécologie, obstétrique, fertilité & sénologie, 2017-01, Vol.45 (1), p.3-4

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer

Pain (Amsterdam), 2017-06, Vol.158 (6), p.1118-1125

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Annals of oncology, 2006-01, Vol.17 (1), p.85-92

2006

Link zum Volltext

Verfügbarkeit prüfen

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

Genetics in medicine, 2010-12, Vol.12 (12), p.801-807

2010

Link zum Volltext

Verfügbarkeit prüfen

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas : Results of a french society of paediatric oncology phase II study

Cancer, 2005-12, Vol.104 (12), p.2792-2797

2005

Link zum Volltext

Verfügbarkeit prüfen

French version of FACT-G: validation and comparison with other cancer-specific instruments

European journal of cancer (1990), 2004-10, Vol.40 (15), p.2243-2252

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

Critical reviews in oncology/hematology, 2010-10, Vol.76 (1), p.71-78

2010

Link zum Volltext

Verfügbarkeit prüfen

Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Gynécologie, obstétrique, fertilité & sénologie, 2022-02, Vol.50 (2), p.121-129

2022

Link zum Volltext

Verfügbarkeit prüfen

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

Annals of oncology, 2001-03, Vol.12 (3), p.397-404

2001

Link zum Volltext

Verfügbarkeit prüfen

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Familial cancer, 2012-06, Vol.11 (2), p.269-278

2012

Link zum Volltext

Verfügbarkeit prüfen

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

Annals of oncology, 2006-01, Vol.17 (1), p.65-73

2006

Link zum Volltext

Verfügbarkeit prüfen

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i7-i9

2005

Link zum Volltext

Verfügbarkeit prüfen

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3115-3124

the French Epirubicin Study Group

2000

Link zum Volltext

Verfügbarkeit prüfen

Cancer genetics: estimation of the needs of the population in France for the next ten years

Bulletin du cancer, 2009-09, Vol.96 (9), p.875

2009

Link zum Volltext

Verfügbarkeit prüfen

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1 2 mutations

European journal of human genetics : EJHG, 2011-05, Vol.19 (5), p.500-506

2011

Link zum Volltext

Verfügbarkeit prüfen

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

British journal of cancer, 2003-08, Vol.89 (S1), p.S17-S31

2003

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study

European journal of cancer (1990), 2012-01, Vol.48 (1), p.101-107

2012

Link zum Volltext

Verfügbarkeit prüfen

Mutation analysis of PALB2 gene in French breast cancer families

Breast cancer research and treatment, 2015-12, Vol.154 (3), p.463-471

2015

Link zum Volltext

Verfügbarkeit prüfen

The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation

International journal of radiation oncology, biology, physics, 1994-07, Vol.29 (4), p.673-679

1994

Link zum Volltext

Verfügbarkeit prüfen

Quality of life in long-term survivors of oropharynx carcinoma

International journal of radiation oncology, biology, physics, 2002-11, Vol.54 (3), p.742-751

2002

Link zum Volltext

Verfügbarkeit prüfen

Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality

International journal of epidemiology, 2000-04, Vol.29 (2), p.214-223

2000

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study

Gynecologic oncology, 1999-11, Vol.75 (2), p.187-193

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 87

Suche als RSS-Feed

Aktive Filter

ThemaSciences Medicales

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(87)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(87)
Female
(75)
Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Middle Aged
(59)
Aged
(52)
Oncology
(50)
Adult
(49)
Male
(36)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Aged, 80 And Over
(30)
Retrospective Studies
(24)
Prognosis
(22)
Radiology, Nuclear Medicine & Medical Imaging
(21)
Radiotherapy Dosage
(19)
Survival Analysis
(18)
Breast Cancer
(17)
France
(17)
Neoplasm Staging
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

PALB2, a major susceptibility gene for breast cancer

Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Breast cancer management: The change is now!

Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas : Results of a french society of paediatric oncology phase II study

French version of FACT-G: validation and comparison with other cancer-specific instruments

Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)

Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study

French women’s breast self-examination practices with time after undergoing BRCA1/2 genetic testing

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials

ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer

Epirubicin-Based Chemotherapy in Metastatic Breast Cancer Patients: Role of Dose-Intensity and Duration of Treatment

Cancer genetics: estimation of the needs of the population in France for the next ten years

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1 2 mutations

Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009–2010: The AnemOnHe study

Mutation analysis of PALB2 gene in French breast cancer families

The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation

Quality of life in long-term survivors of oropharynx carcinoma

Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality

A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study

Aktive Filter

Suchergebnisse filtern